Assoc. Prof. GÜL YALÇIN ÇAKMAKLI

Publication Network

Articles 45

1. Neuropsychological response to ventriculoperitoneal shunting in idiopatic normal pressure hydrocephalus: early gains and the importance of baseline cognition

Yetim E., Charehsaz a., Çekiç E., Akyay A., Isikay I., Cakmakli G. Y., et al.

Acta Medica , vol.56, no.3, pp.178-185, 2025 (TRDizin)

2. Multimodal imaging analysis of autosomal recessive Parkinson's disease

SOYDAŞ TURAN B., Yalcin-cakmakli G., ERGÜN E., Dasgin H., Karli Oguz K., ELİBOL B., et al.

ANNALS OF NUCLEAR MEDICINE , 2025 (SCI-Expanded, Scopus)

3. Distinguishing Alzheimer's disease from Parkinson's disease dementia using Enhanced Cued Recall test subscores

ARSAVA E. M., Demirel E., Akyay A., YALÇIN ÇAKMAKLI G., SAKA TOPÇUOĞLU E.

TURKISH JOURNAL OF NEUROLOGY , vol.31, no.1, pp.62-68, 2025 (ESCI, Scopus, TRDizin) Sustainable Development

4. The impact of perioperative aspirin utilization on postoperative hemorrhagic complications in idiopathic normal pressure hydrocephalus: a single-center retrospective analysis

IŞIKAY A. İ., ÇEKİÇ E., Charehsaz A., Uyaniker Z. A., YALÇIN ÇAKMAKLI G., GÖÇMEN R., et al.

NEUROSURGICAL REVIEW , no.1, 2025 (SCI-Expanded, Scopus)

5. Is high AFP associated with liver diseases in ataxia-telangiectasia and ataxia-oculomotor apraxia?

Ismayilov R., ÖZÜM T., ERSAL DEREGÖZÜ E., Israfilov S., Abdurrahimli N., YALÇIN ÇAKMAKLI G., et al.

HEPATOLOGY FORUM , vol.6, no.1, pp.11-15, 2025 (ESCI, TRDizin)

6. Targeted resequencing reveals high-level mosaicism for a novel frameshift variant in WDR45 associated with beta-propeller protein-associated neurodegeneration

Susgun S., DEMİREL M., YALÇIN ÇAKMAKLI G., Salman B., Oguz K. K., ELİBOL B., et al.

International Journal of Neuroscience , no.10, pp.1040-1045, 2024 (SCI-Expanded, Scopus)

7. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study

Westenberger A., Skrahina V., Usnich T., Beetz C., Vollstedt E., Laabs B., et al.

BRAIN , vol.147, no.8, pp.2652-2667, 2024 (SCI-Expanded, Scopus)

8. Variant-specific effects of GBA1 mutations on dopaminergic neuron proteostasis

Onal G., YALÇIN ÇAKMAKLI G., Özçelik C., Boussaad I., Şeker U., Fernandes H. J. R., et al.

Journal of Neurochemistry , 2024 (SCI-Expanded, Scopus)

9. The effects of exergames on upper extremity performance, trunk mobility, gait, balance, and cognition in Parkinson’s disease: a randomized controlled study

ÇETİN B., KILINÇ M., Çakmaklı G. Y.

Acta Neurologica Belgica , 2024 (SCI-Expanded, Scopus)

10. Could miglustat be a potential candidate in the treatment of action myoclonus renal failure syndrome?

ERDOĞAN S., YALÇIN ÇAKMAKLI G., ELİBOL B., CEYLANER S., AKBOSTANCI M. C.

Acta Neurologica Belgica , vol.123, no.6, pp.2441-2444, 2023 (SCI-Expanded, Scopus)

11. Disclosing the news of future risk of Parkinson's disease: What do patients think?

YILMAZ R., Dilek G. R., Kayis G., Abali T., YALÇIN ÇAKMAKLI G., ARDA B., et al.

Parkinsonism and Related Disorders , vol.116, 2023 (SCI-Expanded, Scopus)

12. Cockayne syndrome type 3 with dystonia-ataxia and clicking blinks

GÜLTEKİN ZAİM Ö. B., YALÇIN ÇAKMAKLI G., Çolpak A. İ., ŞİMŞEK KİPER P. Ö., ÜTİNE G. E., ELİBOL B.

Movement Disorders Clinical Practice , vol.10, no.S3, 2023 (SCI-Expanded, Scopus)

13. Acute effects of lumbosacral mobilization on balance and functional activities in idiopathic Parkinson’s disease:A randomised controlled trial

Seçkinoğulları B., Balkan A. F., Çakmaklı G. Y., AKSOY S., ELİBOL B.

Neurological Research , vol.45, no.8, pp.745-752, 2023 (SCI-Expanded, Scopus)

14. Do cervical stabilization exercises change the effects of conventional exercises in patients with Parkinson’s disease?

Demircan E. N., KÖSE N., Çakmaklı G. Y., AKSOY S., GÖÇMEN R., ZENGİN H. Y., et al.

Neurological Research , vol.45, no.10, pp.936-946, 2023 (SCI-Expanded, Scopus)

15. Novel WDR45 frameshift variant detected by whole exome sequencing in beta-propeller protein-associated neurodegeneration disease

Susgun S., DEMİREL M., YALÇIN ÇAKMAKLI G., ELİBOL B., Iseri S. U., Yapici Z.

EUROPEAN JOURNAL OF HUMAN GENETICS , vol.30, no.SUPPL 1, pp.304-305, 2022 (SCI-Expanded, Scopus)

16. Spectral analysis of lithium tremor

YALÇIN ÇAKMAKLI G., AYHAN Y., Yazıcı M. K., Demirci M., Şahin G.

Archives of Neuropsychiatry , vol.58, pp.268-273, 2021 (SCI-Expanded, Scopus, TRDizin)

17. Higher alpha-synuclein aggregate density does not lead to more severe dopaminergic cell loss in the AAV-mediated overexpression model of Parkinson's Disease: A time-course study

TEL B. C., KAZKAYASI İ., TELLİ G., Cinar E., Mutluay S. U., YALÇIN ÇAKMAKLI G., et al.

JOURNAL OF RESEARCH IN PHARMACY , vol.25, no.3, pp.352-358, 2021 (ESCI, Scopus, TRDizin)

18. Comparative Analysis of Cognitive Profiles of Huntington's and Parkinson's Diseases

YALÇIN ÇAKMAKLI G., Akpulat G. E. G., Celebi O., SAKA TOPÇUOĞLU E., ELİBOL B.

TURKISH JOURNAL OF NEUROLOGY , vol.26, no.3, pp.230-234, 2020 (ESCI, Scopus, TRDizin)

19. Modelling cognitive deficits in Parkinson's disease: Is CA2 a gateway for hippocampal synucleinopathy?

Cinar E., Yalcin-Cakmakli G., Saka E., Ulusoy A., Yuruker S., ELİBOL B., et al.

EXPERIMENTAL NEUROLOGY , vol.330, 2020 (SCI-Expanded, Scopus)

20. Frequency of non-motor symptoms and their impact on the quality of life in patients with Parkinson's disease: a prospective descriptive case series

Gulunay A., YALÇIN ÇAKMAKLI G., YÖN M. İ., Ulusoy E. K., Karakoc M.

PSYCHOGERIATRICS , vol.20, no.2, pp.206-211, 2020 (SCI-Expanded, Scopus) Sustainable Development

21. Motor Dysfunction and Related Synaptic Organisation in AVV-Mediated Alpha-Synuclein Overexpression Model of Parkinson’s Disease AAV-aracılı alfa-sinüklein aşırı ifadesi ile sağlanan parkinson hastalığı modelinde motor bozukluklar ve ilişkili sinaptik organizasyon

Cinar E., YALÇIN ÇAKMAKLI G., TEL B. C.

Hacettepe University Journal of the Faculty of Pharmacy , vol.40, no.2, pp.74-82, 2020 (Scopus) Sustainable Development

22. Lack of Accredited Clinical Training in Movement Disorders in Europe, Egypt, and Tunisia

Tamas G., Fabbri M., Falup-Pecurariu C., Teodoro T., Kurtis M. M., Aliyev R., et al.

JOURNAL OF PARKINSONS DISEASE , vol.10, no.4, pp.1833-1843, 2020 (SCI-Expanded, Scopus)

23. Neuroprotective Treatments in Parkinson’s Disease

ÇINAR E., YALÇIN ÇAKMAKLI G., TEL B. C.

Turkish Journal of Neurology , vol.25, no.4, pp.189-197, 2019 (ESCI, Scopus, TRDizin)

24. Macrocytic anemia in Lesch-Nyhan disease and its variants

Cakmakli H. F., Torres R. J., Menendez A., YALÇIN ÇAKMAKLI G., Porter C. C., Puig J. G., et al.

GENETICS IN MEDICINE , vol.21, no.2, pp.353-360, 2019 (SCI-Expanded, Scopus)

25. Diagnostic challenge A case of late-onset spinal form cerebrotendinous xanthomatosis

MUTLU D., Tuncer A., GÖÇMEN R., YALÇIN ÇAKMAKLI G., SAYGI S., ELİBOL B.

NEUROLOGY , vol.92, no.9, pp.438-439, 2019 (SCI-Expanded, Scopus)

26. Use of anti-Parkinson medication during pregnancy: a case series

Tufekcioglu Z., Hanagasi H., YALÇIN ÇAKMAKLI G., ELİBOL B., Tokucoglu F. E., Kaya Z. E., et al.

JOURNAL OF NEUROLOGY , vol.265, no.8, pp.1922-1929, 2018 (SCI-Expanded, Scopus)

27. Striatal Cholinergic Interneurons in a Knock-in Mouse Model of L-DOPA-Responsive Dystonia

Yalcin-Cakmakli G., Rose S. J., Villalba R. M., Williams L., Jinnah H. A., Hess E. J., et al.

FRONTIERS IN SYSTEMS NEUROSCIENCE , vol.12, 2018 (SCI-Expanded, Scopus)

28. Striatal Neurotransmitter Release-related Presynaptic Proteins in L-dopa Induced Dyskinesia in a Model of Parkinsonism

YALÇIN ÇAKMAKLI G., VURAL A., EREN KOÇAK E., ELİBOL B., Saka E.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.55, no.1, pp.73-79, 2018 (SCI-Expanded, Scopus, TRDizin)

29. Parkinson's Disease

TEL B. C., YALÇIN ÇAKMAKLI G.

NANOTECHNOLOGY METHODS FOR NEUROLOGICAL DISEASES AND BRAIN TUMORS: DRUG DELIVERY ACROSS THE BLOOD-BRAIN BARRIER , pp.241-269, 2017 (SCI-Expanded)

30. Pathophysiology underlying drooling in Parkinson's disease: oropharyngeal bradykinesia

Karakoc M., YÖN M. İ., YALÇIN ÇAKMAKLI G., Ulusoy E. K., Gulunay A., Oztekin N., et al.

NEUROLOGICAL SCIENCES , vol.37, no.12, pp.1987-1991, 2016 (SCI-Expanded, Scopus) Sustainable Development

31. Bazal Gangliyonların Fonksiyonel Organizasyonu:Güncel Anlayışlar ve Hareket Hastalıklarının Tedavisindeki Yansımaları

YALÇIN ÇAKMAKLI G., ELİBOL B.

Türkiye Klinikleri Journal of Neurology Hareket Bozuklukları Özel Sayısı , vol.8, no.2, pp.9-19, 2015 (Peer-Reviewed Journal)

32. A new Turkish family with homozygous FBX07 truncating mutation and juvenile atypical parkinsonism

Yalcin-Cakmakli G., Olgiati S., Quadri M., Breedveld G. J., Cortelli P., Bonifati V., et al.

PARKINSONISM & RELATED DISORDERS , vol.20, no.11, pp.1248-1252, 2014 (SCI-Expanded, Scopus)

33. The Status of the Neurology Education from Resident's Perspective: A National Survey in Turkey

ÇAĞLAYAN H. Z. B., Ege F., Bastan B., YALÇIN ÇAKMAKLI G., ÇAPRAZ İ., ARSAVA E. M., et al.

TURKISH JOURNAL OF NEUROLOGY , vol.20, no.3, pp.72-75, 2014 (ESCI, Scopus)

34. Recurrent optic neuritis: clues from a long-term follow up study of recurrent and bilateral optic neuritis patients

Kurne A., KARABUDAK R., YALÇIN ÇAKMAKLI G., Gursoy-Ozdemir Y., Aydin P., Ilksen-Colpak A., et al.

EYE AND BRAIN , vol.2, pp.15-20, 2010 (ESCI, Scopus)

35. Hyponatremic Encephalopathy after Excessive Water Ingestion Prior to Pelvic Ultrasound: Neuroimaging Findings

Yalcin-Cakmakli G., Oguz K. K., Shorbagi A., Bas D. F., Ergan-Arsava B., Kunt M. M., et al.

INTERNAL MEDICINE , vol.49, no.16, pp.1807-1811, 2010 (SCI-Expanded, Scopus)

36. Downbeat nystagmus due to oxcarbazepine intoxication

YALÇIN ÇAKMAKLI G., DERİCİOĞLU N., Kansu T.

TURKISH JOURNAL OF NEUROLOGY , vol.15, no.3, pp.149-152, 2009 (TRDizin)

37. Childhood optic neuritis: The pediatric neurologist's perspective

Cakmakli G., Kurne A., Guven A., Serdaroglu A., Topaloglu H., Teber S., et al.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY , vol.13, no.5, pp.452-457, 2009 (SCI-Expanded, Scopus)

38. An unusual central nervous system involvement in rheumatoid arthritis: combination of pachymeningitis and cerebral vasculitis

Kurne A., KARABUDAK R., KARADAĞ Ö., Yalcin-Cakmakli G., Karli-Oguz K., Yavuz K., et al.

RHEUMATOLOGY INTERNATIONAL , vol.29, no.11, pp.1349-1353, 2009 (SCI-Expanded, Scopus)

39. Reversible acute cognitive dysfunction induced by bilateral STN stimulation

Cakmakli G. Y., Oruckaptan H., Saka E., ELİBOL B.

JOURNAL OF NEUROLOGY , vol.256, no.8, pp.1360-1362, 2009 (SCI-Expanded, Scopus)

40. Right Internal Carotid Artery Occlusion during Intravenous Thrombolysis for Left Middle Cerebral Artery Occlusion

Yalcin-Cakmakli G., AKPINAR E., TOPÇUOĞLU M. A., DALKARA T.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES , vol.18, no.1, pp.74-77, 2009 (SCI-Expanded, Scopus)

41. Department of Neurology, Faculty of Medicine, University of Hacettepe, Ankara, Turkey

YALÇIN ÇAKMAKLI G., DERİCİOĞLU N.

TURKISH JOURNAL OF NEUROLOGY , vol.15, no.3, pp.149-152, 2009 (ESCI, TRDizin)

42. Recurrent alien hand syndrome in a multiple sclerosis case

Kurne A., Cakmakli G. Y., KARABUDAK R.

NEUROLOGIST , vol.14, no.5, pp.316-317, 2008 (SCI-Expanded, Scopus)

43. Diabetic uremic syndrome

Yalcin G., Ozgen B., VARLI K., TOPÇUOĞLU M. A.

JOURNAL OF NEUROLOGY , vol.255, no.9, pp.1415-1416, 2008 (SCI-Expanded, Scopus) Sustainable Development

44. Drug induced intracranial hypertension associated with sulphasalazine treatment

Sevgi E., Yalcin G., Kansu T., VARLI K.

HEADACHE , vol.48, no.2, pp.296-298, 2008 (SCI-Expanded, Scopus)

45. Effects of freezing of gait on balance in patients with Parkinson’s disease

Korkusuz S., Seçkinoğulları B., Özcan A., Demircan E. N., Çakmaklı G. Y., ARMUTLU K., et al.

Neurological Research , vol.45, no.5, pp.407-414, 1 (SCI-Expanded, Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences 58

1. Alzheimer Hastalığı ve Parkinson Hastalığı İlişkili Kognitif Kayıpta Artırılmış İp Uçlu Hatırlama Testi Alt Testleri ve Bölgesel Kortikal Kalınlık Farkı İlişkisinin Karşılaştırılması

DEMİREL E., YETİM ARSAVA E., Akyay A., YALÇIN ÇAKMAKLI G., SAKA TOPÇUOĞLU E.

59. Ulusal Nöroloji Kongresi, Antalya, Turkey, 12 - 18 December 2023, (Summary Text)

2. Artırılmış İp uçlu Hatırlama Testi Alt Skorlarının Alzheimer Hastalığı ve Parkinson Hastalığı İlişkili Kognitif Kaybın Ayırıcı Tanısında Kullanımı

YETİM ARSAVA E., DEMİREL E., Akyay A., YALÇIN ÇAKMAKLI G., SAKA TOPÇUOĞLU E.

13. Ulusal Alzheimer Kongresi, Muğla, Turkey, 12 - 15 October 2023, (Summary Text)

3. Multimodal imaging analysis of autosomal recessive Parkinson's disease

SOYDAŞ B., YALÇIN ÇAKMAKLI G., YETİM ARSAVA E., VOLKAN SALANCI B., ERGÜN E., KARLI OĞUZ H. K., et al.

2023 International Congress of Parkinson's Disease and Movement Disorders, Kopenhag, Denmark, 27 - 31 August 2023, (Summary Text)

4. İDİYOPATİK NORMAL BASINÇLI HİDROSEFALİ’NİN KOGNİTİF TUTULUM PATOGENEZİNDE VENTRİKÜL MÜ SUBARAKNOİD MESAFE Mİ?

YETİM ARSAVA E., BAHADIR Ş., YALÇIN ÇAKMAKLI G., IŞIKAY A. İ., GÖÇMEN R., ELİBOL B.

15. Ulusal Parkinson Hastalığı ve Hareket Bozuklukları Kongresi, Muğla, Turkey, 15 - 19 March 2023, (Full Text)

5. Kronik stresin bellek üzerine etkileri dişi ile erkek farelerde farklı mı?

ESEN E. C., YALÇIN ÇAKMAKLI G., KARATAŞ KURŞUN H., YEMİŞCİ ÖZKAN M., DALKARA T., ELİBOL B., et al.

Ulusal Sinirbilim Kongresi, Turkey, 07 November 2020, (Summary Text)

6. Parkinson Hastalığının Tedavisinde Yakın Gelecek

YALÇIN ÇAKMAKLI G.

HAREKET BOZUKLUKLARININ TANI VE TEDAVİSİNDE ALGORİTMİK YAKLAŞIMLAR SEMPOZYUMU, Turkey, 10 - 11 October 2020, (Summary Text)

7. Hareket Bozuklukları Fonksiyonel Nöroanatomisi

YALÇIN ÇAKMAKLI G.

Çocuk Metabolizma Hastalıkları Akademisi, Metabolik Hastalıklarda Hareket Bozuklukları Sempozyumu, Ankara, Turkey, 5 - 07 March 2020, (Summary Text)

8. Sarkopeni-Kognisyon ve Hareket

YALÇIN ÇAKMAKLI G.

Sarkopeni 5K 1D, Ankara, Turkey, 22 February 2020, (Summary Text)

9. Distoni Genetiği

YALÇIN ÇAKMAKLI G.

3. Nörobilim Kongresi, Farklı Disiplinlerde Aynı Beyin, İstanbul, Turkey, 14 - 15 December 2019, (Summary Text)

10. Fonksiyonel hareket bozukluğu olan distonik bir olgunun tedavi sonuçları.

FİL BALKAN A., KARANFİL E., ARMUTLU K., YALÇIN ÇAKMAKLI G., ELİBOL B., YILDIZ M. İ., et al.

12. Nöropsikiyatri Günleri, İstanbul, Turkey, 6 - 07 December 2019, (Summary Text)

11. The role of microbiota in Parkinson’s disease

YALÇIN ÇAKMAKLI G.

7th International Congress of Molecular Medicine, İstanbul, Turkey, 5 - 07 September 2019, (Summary Text)

12. Retinal and choroidal findings in autosomal recessive parkinson’s disease are similar to those in idiopathic parkinson’s disease

KADAYIFÇILAR S., AĞIN A., ÇOLPAK IŞIKAY A. İ., YALÇIN ÇAKMAKLI G., BİLGİÇ A. A., ELİBOL B., et al.

EURETINA, Paris, France, 5 - 08 September 2019, (Summary Text)

13. Generation and characterization of iPSC lines derived from patients with GBA mutations

ÖNAL G., YALÇIN ÇAKMAKLI G., ELİBOL B., Yüce A., Krüger R., DÖKMECİ S.

13th European Working Group on Gaucher Disease Meeting, Clermont-Ferrand, France, 4 - 06 July 2019, pp.50, (Summary Text)

14. Konversiyon bozukluğu (İşlevsel Nörolojik Belirti Bozukluğu): Terminoloji, Tanı ve Ayırıcı Tanı

YALÇIN ÇAKMAKLI G.

23. Türk Psikiyatri Derneği Yıllık Toplantısı ve Klinik Eğitim Sempozyumu, Turkey, 10 - 13 April 2019, vol.30, pp.34, (Summary Text)

15. RAPAMYCIN TREATMENT ENHANCES COGNITIVE FUNCTION IN THE AAV-MEDIATED HIPPOCAMPAL ALPHA-SYNUCLEINOPATHY IN RAT

Çınar E., Yalçın Çakmaklı G., Saka Topçuoğlu E., Tel B. C., Elibol B.

14th International Conference on Alzheimer’s and Parkinson’s Diseases AD/PD 2019, Lisbon, Portugal, 26 - 31 March 2019, (Summary Text)

16. A promising model for cognitive dysfunction in Parkinson’xxs Disease by AAV-mediated alpha-synuclein overexpression in hippocampus

Yalçın Çakmaklı G., Çınar E., Saka Topçuoğlu E., Ulusoy A., Tel B. C., Elibol B.

International Congress of Parkinson’xxs Disease and Movement Disorders, Victoria-City, Hong Kong, 5 - 09 October 2018, vol.33, pp.586, (Summary Text)

17. Retinal and choroidal changes in autosomal recessive PD are similar to idiopathic PD

ÇOLPAK IŞIKAY A. İ., Ağın a., YALÇIN ÇAKMAKLI G., KADAYIFÇILAR S., Bilgiç A. A., ELDEM M. B., et al.

International Congress of Parkinson’xxs Disease and Movement Disorders, Hong Kong, Hong Kong, 5 - 09 October 2018, vol.33, pp.721, (Summary Text)

18. A promising model for cognitive dysfunction in Parkinson’s Disease by AAV-mediated alpha-synuclein overexpression in hippocampus

Çınar E., Yalçın Çakmaklı G., Saka Topçuoğlu E., Tel B. C., Elibol B.

22nd International Congress of Parkinson’s Disease and Movement Disorders (MDS), Victoria-City, Hong Kong, 5 - 09 October 2018, (Summary Text)

19. Analysis of genetic background in Turkish early onset Parkinson’s disease patients

AKBABA T. H., ÖNAL G., YÜZBAŞIOĞLU A., YALÇIN ÇAKMAKLI G., PEYNİRCİOĞLU B., ÖZGÜÇ M., et al.

6th International Congress of the Molecular Biology Association of Turkey, İzmir, Turkey, 05 September 2018, pp.46, (Full Text)

20. Synaptic loss predominates neuronal loss in a PD model of AAV-mediatedalpha-synuclein overexpression in hippocampus and striatum

ÇINAR E., YALÇIN ÇAKMAKLI G., SAKA TOPÇUOĞLU E., ELİBOL B., TEL B. C.

18th World Congress of Basic and Clinical Pharmacology (WCP2018), 1 - 06 July 2018, (Summary Text)

21. AVV-aracılı Alfa-sinüklein Aşırı İfadesine Dayalı Parkinson Hastalığı Sıçan Modelinde Motor ve Non-motor Belirtiler

ÇINAR E., YALÇIN ÇAKMAKLI G., TEL B. C., SAKA TOPÇUOĞLU E., ELİBOL B.

Ulusal Sinirbilim Kongresi, Turkey, 20 - 23 May 2018, (Summary Text) Sustainable Development

22. AVV-aracılı Parkinson hastalığı alfa-sinüklein sıçan modelinde motor ve non-motor belirtiler

Çınar E., Yalçın Çakmaklı G., Tel B. C., Saka Topçuoğlu E., Elibol B.

16. Ulusal Sinirbilim Kongresi, İstanbul, Turkey, 20 - 23 May 2018, pp.102, (Summary Text)

23. AAV-aracılı Alfa-sinükleinopati Modelinde Zamana Bağlı Motor Değişiklikler

ÇINAR E., TEL B. C., YALÇIN ÇAKMAKLI G., SAKA TOPÇUOĞLU E., ELİBOL B.

HÜCRE ÖLÜMÜ ARAŞTIRMA DERNEĞİULUSLARARASI KATILIMLINÖRODEJENERASYON / NÖROREJENERASYON ÇALIŞTAYI, Turkey, 4 - 05 May 2018, (Summary Text)

24. Demans: Tanım, Fizyopatoloji, Klinik Özellikler ve Tedavi

YALÇIN ÇAKMAKLI G.

49. Ulusal Nöroloji Kongresi, Turkey, 24 - 30 November 2017, (Summary Text)

25. Analysis of genomic rearrangements in aTurkish cohort of early onset Parkinson’sdisease

ÖNAL G., YÜZBAŞIOĞLU A., YALÇIN ÇAKMAKLI G., PEYNİRCİOĞLU B., DÖKMECİ S., ÖZGÜÇ M., et al.

42nd FEBS Congress, 10 - 14 September 2017, (Summary Text)

26. How common are the genomic rearrangements among possiblyautosomal recessive PD cases in Turkey?

YALÇIN ÇAKMAKLI G., YÜZBAŞIOĞLU A., ÖNAL G., PEYNİRCİOĞLU B., ÖZGÜÇ M., DÖKMECİ S., et al.

International Congress of Parkinson’xxs Disease and Movement Disorders, 4 - 08 June 2017, (Summary Text)

27. Differential effects of ventral or dorsal predominant dopaminerjic denervation of striatum on development of dopamine dysregulation syndrome and punding in a rat model of parkinsonism

ÖZKAN E., YALÇIN ÇAKMAKLI G., ELİBOL B., SAKA TOPÇUOĞLU E.

21st International Congress of Parkinson’xxs Disease and Movement Disorders, Vancouver, Canada, 4 - 08 June 2017, vol.32, (Summary Text)

28. Motor dysfunction in AVV-mediated alpha-synuclein overexpression model of Parkinsonism in relation to synaptic organization in striatum

Çınar E., Yalçın Çakmaklı G., Tel B. C., Elibol B.

The 13th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders, AD/PD™ 2017, Vienna, Austria, 29 March - 02 April 2017, (Summary Text)

29. Hippocampal adeno associated viral vector mediated alpha synuclein overexpression A promising model for recapitulating cognitive involvement in Parkinson s disease

ÇINAR E., YALÇIN ÇAKMAKLI G., Mutluay S. U., SAKA TOPÇUOĞLU E., Ulusoy A., TEL B. C., et al.

Society for Neuroscience, Neuroscience 2016, 12 - 16 November 2016, (Summary Text)

30. Increase in the number of striatal cholinergic interneurons in a mouse model of DOPA- responsive dystonia

YALÇIN ÇAKMAKLI G., Villalba R. M., Rose S. J., Hess E. J., Smith Y.

Society for Neuroscience Meeting, San Diego, United States Of America, 12 - 16 November 2016, (Summary Text)

31. Analysis of Genomic Rearrangements in a Turkish cohort of early onset Pwarkinso s Disease

YÜZBAŞIOĞLU A., ÖNAL G., YALÇIN ÇAKMAKLI G., PEYNİRCİOĞLU B., ÖZGÜÇ M., ELİBOL B., et al.

^rd International Parkinson Disease Symposium, 6 - 08 October 2016, (Summary Text)

32. Hippocampal AAV mediated alpha synuclein overexpression leads to synaptic and neuronal loss with minor cognitive deficits as a Parkinson s disease model in rats

ÇINAR E., YALÇIN ÇAKMAKLI G., Mutluay S. U., SAKA TOPÇUOĞLU E., Ulusoy A., TEL B. C., et al.

10th FENS Forum of Neuroscience, 2 - 06 July 2016, (Summary Text)

33. Unilateral AAV mediated alpha synuclein overexpression model of Parkinson disease s to study motor and cognitive dysfunction

TEL B. C., Mutluay S. U., ÇINAR E., YALÇIN ÇAKMAKLI G., SAKA TOPÇUOĞLU E., Ulusoy A., et al.

6th European Congress of Pharmacology Meeting EPHAR 2016, 26 - 30 June 2016, (Summary Text)

34. Parkinsonism due to hypermanganism in the background of cirrhosis and recovery by CaNaEDTA

ELİBOL B., Önder H., YALÇIN ÇAKMAKLI G., SAKA TOPÇUOĞLU E.

International Congress of Parkinson’xxs Disease and Movement Disorders, Berlin, Germany, 19 - 23 June 2016, vol.31, pp.595, (Summary Text)

35. Unilateral AAV aracılı alfa sinüklein aşırı ifadesi ile oluşturulan PH modelinde motor ve bilişsel değişiklikler

TEL B. C., Mutluay S. U., ÇINAR E., YALÇIN ÇAKMAKLI G., SAKA TOPÇUOĞLU E., Ulusoy A., et al.

14. Ulusal Sinirbilim Kongresi, Turkey, 26 - 29 May 2016, (Summary Text) Sustainable Development

36. Adeno ilişkili viral vektör aracılı Parkinson hastalığı modelinde dentat girusta aşırı alfasinüklein ifadesine bağlı bilişsel fonksiyon değişikliklerinin davranışsal ve histopatolojik değerlendirilmesi

ÇINAR E., YALÇIN ÇAKMAKLI G., Mutluay S. U., TELLİ G., KAZKAYASI İ., Ulusoy A., et al.

23. Ulusal Farmakoloji Kongresi, Turkey, 7 - 09 September 2015 Sustainable Development

37. Does higher alpha-synuclein aggregate density lead to more severe dopaminergic cell loss in the AAV-mediated over-expression model of PD?

ÇINAR E., YALÇIN ÇAKMAKLI G., Mutluay S. U., TELLİ G., KAZKAYASI İ., ULUSOY A., et al.

19th International of Parkinson’s Disease and Movement Disorders, United States Of America, 14 June 2015, (Summary Text)

38. Cognitive dysfunction due to over expression of alpha synuclein in hippocampus by using viral vector based approach Modeling cognitive decline in PD

TEL B. C., YALÇIN ÇAKMAKLI G., ÇINAR E., Mutluay S. U., TELLİ G., SAKA TOPÇUOĞLU E., et al.

Movement Disordes Society Meeting 2015, 14 - 18 June 2015

39. Does higher alpha synuclein aggregat density lead to more severe dopaminergic cell loss in AAV mediated over expression model of PD

YALÇIN ÇAKMAKLI G., ÇINAR E., Mutluay S. U., TELLİ G., KAZKAYASI İ., TEL B. C., et al.

Neurizon 2015, 26 - 29 May 2015, (Summary Text)

40. Parkinson hastalığında BOS belirteçlerinin bilişsel işlevlerle ilişkisi

Çelebi Ö., YALÇIN ÇAKMAKLI G., Uzdoğan A., Akbıyık F., ELİBOL B., SAKA TOPÇUOĞLU E.

11. Ulusal Hareket Bozuklukları Kongresi, Antalya, Turkey, 15 - 19 April 2015, vol.18, (Summary Text)

41. What is the difference between the cognitive profiles of Huntington’s and PD?

YALÇIN ÇAKMAKLI G., Genç Akpulat G. E., Çelebi Ö., SAKA TOPÇUOĞLU E., ELİBOL B.

The 13th International Conference on Alzheimer’xxs and Parkinson’s Diseases and Related Neurological Disorders, AD/PD™ 2015, Nice, France, 18 - 22 March 2015, (Summary Text)

42. Huntington Hastalığı’nın bilişsel profili Parkinson hastalığınınkinden farklı mıdır?

Genç Akpulat G. E., YALÇIN ÇAKMAKLI G., Çelebi Ö., SAKA TOPÇUOĞLU E., ELİBOL B.

50. Ulusal Nöroloji Kongresi, Antalya, Turkey, 21 - 27 November 2014, (Summary Text)

43. Hipokampüste AAV-aracılı alfa-sinüklein aşırı ifadesi ile PH modelinde kognitif değişiklikler oluşturulabilir mi?

Yalçın Çakmaklı G., Çınar E., Kazkayası İ., Telli G., Mutluay S. U., Saka Topçuoğlu E., et al.

12. Ulusal Sinirbilim Kongresi, İstanbul, Turkey, 28 - 31 May 2014, vol.77, pp.17, (Summary Text) Sustainable Development

44. Another cause of reversible splenial lesion: Hepatic encephalopathy

Ak F., YALÇIN ÇAKMAKLI G., YÖN M. İ., Duran S., ÖZTEKİN Z. N.

World Congress of Neurology, Viyana, Austria, 21 - 26 September 2013, (Summary Text)

45. Beyond Klüver-Bucy Syndrome: Colorful clinical picture of bilateral anterior cerebral artery infarction

Ak F., YALÇIN ÇAKMAKLI G., Karakoç M., TAŞKIRAN SAĞ A., ÖZTEKİN Z. N.

World Congress of Neurology, Viyana, Austria, 21 - 26 September 2013, (Summary Text)

46. Pathophysiology underlying drooling in PD: Bradykinesia of swallowing

Karakoç M., YALÇIN ÇAKMAKLI G., ÖZTEKİN Z. N., Ak F.

17th International Congress of Parkinson’s Disease and Movement Disorders, Sydney, Australia, 16 - 20 June 2013, (Summary Text)

47. The impact of non-motor symptoms on quality of life in PD and dopamine dysregulation syndrome

YALÇIN ÇAKMAKLI G., Gülünay A., Bilen Ş., ÖZTEKİN Z. N., Ak F.

17th International Congress of Parkinson’s Disease and Movement Disorders, Sydney, Australia, 16 - 20 June 2013, (Summary Text)

48. Kalıcı Konjenital Ayna Hareketleri: TMS ışığında Patofizyolojik Mekanizma Tartışması

Altaş S., YALÇIN ÇAKMAKLI G., TEMUÇİN Ç. M., SÜCÜLLÜ KARADAĞ Y., ÖZTEKİN Z. N., Ak F.

48. Ulusal Nöroloji Kongresi, Antalya, Turkey, 16 - 22 November 2012, pp.46, (Summary Text)

49. PET ile tanısı kesinleştirilmiş Primer Progresif Afazi Olguları: Videolu Sunum

Altan G., YALÇIN ÇAKMAKLI G., Arlı B., ÖZTEKİN Z. N., Ak F.

48. Ulusal Nöroloji Kongresi, Antalya, Turkey, 16 - 22 November 2012, pp.26, (Summary Text)

50. Dopamine dysregulation syndrome, dyskinesia and non-motor wearing off case report

SÜCÜLLÜ KARADAĞ Y., ÖZTEKİN Z. N., Gülünay A., YALÇIN ÇAKMAKLI G., Ak F.

16th EFNS meeting, 8 - 11 September 2012, vol.19, (Summary Text)

51. Striatal neurotransmitter release-related presynaptic proteins in L-dopa induced dyskinesia in 6-hydroxydopamine model of parkinsonism

YALÇIN ÇAKMAKLI G., VURAL A., EREN KOÇAK E., ELİBOL B., SAKA TOPÇUOĞLU E.

14th International Congress of Parkinson’s Disease and Movement Disorders, Buenos Aires, Argentina, 13 - 17 June 2010, (Summary Text)

52. Lityum tremorunun spektral analizi

YALÇIN ÇAKMAKLI G., Şahin G., AYHAN Y., Yazıcı M. K., Demirci M.

8. Ulusal Hareket Bozuklukları ve Parkinson Hastalığı Kongresi, Muğla, Turkey, 30 - 04 September 2009, (Summary Text)

53. Reversible acute cognitive dysfunction induced by bilateral STN stimulation

YALÇIN ÇAKMAKLI G., Oruçkaptan H., SAKA TOPÇUOĞLU E., ELİBOL B.

12th International Congress of Parkinsons Disease and Movement Disorders, Chicago, United States Of America, 22 - 26 June 2008, vol.23, pp.126-127, (Summary Text)